# A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030)

> **NCT06575959** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 20 (actual)

## Conditions studied

- Hepatic Insufficiency
- Hepatic Impairment

## Interventions

- **DRUG:** Enlicitide

## Key facts

- **NCT ID:** NCT06575959
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-20
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-05-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06575959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06575959, "A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06575959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*